Newsfeeds - Spark Newswire

2 minute read

Applied DNA Sciences Wins Suffolk County Community College COVID-19 Testing Contract, No Terms Disclosed

Today, 10:29 PM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced that its

APDN

1 minute read

HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Lowers Price Target to $11

By Benzinga Newsdesk

Today, 10:29 PM

HC Wainwright & Co. analyst Yi Chen maintains Applied DNA Sciences (NASDAQ:APDN) with a Buy and lowers the price target from $13 to $11.

APDN

1 minute read

Earnings

Recap: Applied DNA Sciences Q3 Earnings

By Benzinga Insights

Today, 10:29 PM

Shares of Applied DNA Sciences (NASDAQ:APDN) fell 7.8% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 36.11% year over year to ($0.46), which missed the estimate of ($0.22).

APDN

1 minute read

Applied DNA Sciences Q3 EPS $(0.46) Misses $(0.22) Estimate, Sales $1.70M Miss $3.13M Estimate

By Michael Horton

Today, 10:29 PM

Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.22) by 109.09 percent. This is a 36.11 percent increase over losses of $(0.72) per

APDN

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 10:29 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

15 minute read

Earnings Scheduled For August 12, 2021

By Benzinga Insights

Today, 10:29 PM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

3 minute read

20 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 10:29 PM

Gainers Windtree Therapeutics, Inc. (NASDAQ: WINT) shares rose 55.8% to $2.82 in pre-market trading after dropping over 10% on Friday. The company recently reported a wider loss for its second quarter.

ACER

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 10:29 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL